CVS Health Corporation (CVS) Shares Bought by Brandes Investment Partners LP
Brandes Investment Partners LP grew its position in shares of CVS Health Corporation (NYSE:CVS) by 0.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 94,408 shares of the pharmacy operator’s stock after buying an additional 137 shares during the period. Brandes Investment Partners LP’s holdings in CVS Health Corporation were worth $7,596,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the business. Gemmer Asset Management LLC lifted its holdings in shares of CVS Health Corporation by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares during the last quarter. TB Alternative Assets Ltd. bought a new stake in shares of CVS Health Corporation in the 2nd quarter worth approximately $121,000. SRS Capital Advisors Inc. lifted its holdings in shares of CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after purchasing an additional 734 shares during the last quarter. Grace & White Inc. NY bought a new stake in shares of CVS Health Corporation in the 2nd quarter worth approximately $199,000. Finally, Nadler Financial Group Inc. bought a new stake in shares of CVS Health Corporation in the 2nd quarter worth approximately $202,000. 82.04% of the stock is currently owned by institutional investors.
CVS Health Corporation (NYSE:CVS) opened at $71.48 on Tuesday. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $71,912.30, a price-to-earnings ratio of 12.43, a P/E/G ratio of 1.22 and a beta of 0.86. CVS Health Corporation has a 1-year low of $66.45 and a 1-year high of $84.72.
CVS Health Corporation (NYSE:CVS) last issued its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.64 EPS. analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, November 3rd. Investors of record on Tuesday, October 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date was Monday, October 23rd. CVS Health Corporation’s payout ratio is 41.32%.
In related news, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health Corporation stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the transaction, the executive vice president now directly owns 43,178 shares in the company, valued at approximately $3,504,758.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas M. Moriarty sold 90,267 shares of CVS Health Corporation stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.61, for a total value of $7,186,155.87. Following the completion of the transaction, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The disclosure for this sale can be found here. Insiders sold a total of 716,625 shares of company stock worth $58,318,431 over the last 90 days. Insiders own 0.61% of the company’s stock.
Several analysts recently issued reports on CVS shares. Robert W. Baird reissued a “hold” rating and issued a $77.00 price target on shares of CVS Health Corporation in a report on Friday, October 27th. BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Mizuho set a $90.00 price target on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, October 24th. Loop Capital assumed coverage on CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 price target on the stock. Finally, Needham & Company LLC restated a “hold” rating on shares of CVS Health Corporation in a research report on Sunday, September 10th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $85.82.
CVS Health Corporation Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.